Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
Times cited: 2
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Times cited: 31
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Times cited: 39